Compliance
Industry Insight
The Real Cost of Not Testing Right: A Sourcing Team's Calculation
The ratio between a preventable test and an actual recall is not close. Here is why testing budgets get cut anyway, and how to fix that.

Here's a number that tends to focus a room.
When a product is recalled from the EU market because of a REACH violation, the average recovery cost for the brand, including logistics for collection from retail, product disposal, regulatory engagement, supply chain investigation, and internal management time, runs between 200,000 and 2 million. That's a range that covers the scale from a small regional distribution recall to a large multi-market recall of a significant product line. And it's before any regulatory fine, which can add considerably more. And before the reputational cost, which doesn't appear on a balance sheet but absolutely shows up in the next round of supplier selection conversations.
The cost of the RSL test that would have caught the chemical violation before the product left Pakistan: somewhere between 80 and 300 per test panel, depending on the scope, the laboratory, and the number of parameters required.
Let that ratio settle for a moment. The test that prevents a 500,000 problem costs less than 300. The ratio of prevention cost to remediation cost is somewhere between 1,600:1 and 7,000:1 depending on the scale of the recall.
This is not complicated math. What's complicated is organizational: making sure the people who control the testing budget understand the full cost exposure that budget is protecting against.
Why the testing investment is chronically underfunded: the organizational explanation
Let's be honest about why sourcing teams consistently underinvest in testing, because it's not ignorance and it's not recklessness. It's organizational structure.
Testing costs sit in the sourcing or quality budget as a direct, visible line item. They appear on monthly cost reports. They're subject to budget pressure. When the supply chain finance team asks where costs can be trimmed, pre-shipment testing fees are visible and cuttable.
Recall costs, regulatory fine costs, and supply chain restructuring costs, if they ever materialize, arrive as exceptional charges in a different fiscal quarter, usually categorized as "extraordinary items," "legal and regulatory costs," or "supply chain remediation," and absorbed across multiple departments and P&L lines. The person who approved a cost reduction in the testing budget in Q1 is rarely the person writing the check for the regulatory response in Q4. Frequently, they're in different departments.
This is the fundamental organizational problem. The costs and benefits of testing investment are structurally separated in ways that make the business case hard to see from inside any single budget center.
The solution is not purely financial modeling (though financial modeling helps). It's also about who makes the testing investment decision and whether that person has visibility into the full exposure that testing protects against. Compliance and legal teams typically understand recall exposure. Supply chain and finance teams typically control testing budgets. Getting those groups aligned in the same room with a clear cost comparison is the conversation that changes testing investment levels. The five cost categories that testing prevents: a complete accounting
Most cost-of-non-testing calculations focus on the most dramatic scenario, the large-scale recall. That's the right scenario to use as the headline number. But there are four additional cost categories, each significant on its own, that don't require a recall to materialize.
Category one: re-testing costs from non-accredited reports
A shipment arrives at a buyer's quality office with test reports. The compliance team notices that the reports are from a laboratory not listed in PNAC's accredited database. The test results may be accurate, but the documentation is not internationally recognized compliance evidence.
The buyer requires re-testing at an accredited laboratory before accepting the documentation. The supplier must source new samples (if the original production batch has already shipped) or cut and ship new samples from the held production. The accredited laboratory run takes 5-8 working days. The shipment is held.
On a container-load order of garments, the cost of holding one 40-foot container in Karachi's port while re-testing is arranged runs in the range of USD 500-1,500 per week in storage costs plus any handling fees. If the booking slot to the vessel is missed and the next available slot is two weeks later, there are also vessel rebooking fees.
If the buyer's retail window requires the goods to arrive by a specific date, and the delay causes the goods to miss that date, the buyer may impose late delivery penalties, mark down the goods for a later season, or refuse the shipment. Each of these outcomes has significant cost implications.
All of this is avoidable by confirming laboratory accreditation before the testing is done.
Category two: air freight premium from late compliance documentation
A more common scenario than a customs hold is this: the supplier has goods ready for shipment. The buyer's quality team is waiting for test reports before approving the shipment. The test reports are from an overseas laboratory and take 15 working days to come back. The sea freight booking is at risk of being missed.
When the sea freight booking is missed, the buyer either accepts a two-week delay to the retail window (with commercial consequences) or pays for air freight to meet the schedule. Air freight for a garment order is typically 5-8 times the cost of sea freight per unit. On a 10,000-unit order of garments worth USD 8 FOB each, the sea freight might be USD 3,000-4,000 for the container. The air freight for the same goods: USD 15,000-25,000.
The premium paid for air freight because the testing process wasn't integrated into the production schedule properly, rather than bolted onto the end: that premium is a direct cost of not having a pre-production testing programme. This is the most common hidden cost in Pakistan sourcing compliance. It rarely appears in any "cost of testing" calculation, but it should.
Category three: mark-down losses from retail window misses
When goods arrive after a retail window has passed because of compliance-related delays, they typically get marked down for the following season. The mark-down percentage varies by category, but a seasonal fashion item that misses its window by six weeks may sell at 40-60% of its original retail price in a clearance context.
On a 5,000-unit order with an average retail price of USD 30, the mark-down loss from 40% discount on a 60% clearance sell-through is in the range of USD 25,000-35,000. That's before the margin the supplier was expecting on the original order.
These mark-down losses typically get attributed to "poor supplier performance" in the sourcing team's records. The root cause, insufficient pre-production chemical compliance testing, is less frequently identified.
Category four: the border enforcement cost spiral
EU customs authorities that detect a REACH violation in a shipment typically conduct risk- based follow-up. If a product from a specific supplier or specific brand fails a market surveillance test, the customs authority increases its inspection rate for future shipments from that supplier, that brand, or both.
This means that a compliance failure doesn't just cost what it costs in that moment. It creates a period of elevated inspection rates for subsequent shipments. More shipments selected for testing. More testing delay. More potential for finding additional issues during a period when the supplier and buyer are already under scrutiny.
The enhanced scrutiny period can last 12-24 months. During that time, every shipment carries additional compliance overhead that wouldn't have existed without the original failure.
Category five: supplier relationship and production planning costs
When a compliance failure is identified after production is complete, someone has to figure out what to do with the non-compliant goods. Options are limited: re-export to Pakistan (at the buyer's expense for return freight plus the supplier's cost of rework or disposal), destruction in Europe (regulated and expensive), treatment to achieve compliance (often not technically feasible for chemical violations), or negotiated price reduction on a pass-through basis (where the buyer absorbs some cost to sell the goods into a lower-compliance market).
All of these options consume supplier and buyer relationship capital. Fingers point. Responsibility is disputed. The production line that was going to start the next season's orders is now occupied with discussions about the current season's problem. The supplier relationship cost of a compliance failure is hard to quantify but real. Rebuilding trust after a recall or a significant compliance failure, particularly one that required regulatory engagement, takes seasons.
The insurance framing: the right mental model for testing investment
The right way to think about testing investment is as insurance, but with two important differences from conventional insurance.
The first difference is that the "premium" doesn't just pay out if something goes wrong. It actively reduces the probability of something going wrong. This is more like building safety infrastructure than buying fire insurance. A fire suppression system reduces the probability of a fire becoming a serious problem, not just compensates for it after the fact. Pre-production chemical testing doesn't compensate for a REACH violation. It catches it before it becomes one.
The second difference is that the premium scales with the risk profile of the specific supply chain. A supplier who has three years of clean test history for a consistent product line using verified chemical inputs has a different risk profile from a supplier who recently changed their wet processing sub-contractor. Calibrating testing intensity to actual risk is more efficient than applying uniform testing across all suppliers regardless of their history.
Building the business case for your organisation: the numbers
For any sourcing team that wants to build an internal business case for appropriate testing investment, here's the framework.
Step one: estimate your current Pakistan-origin order volume (in number of shipments per season or per year).
Step two: estimate the probability of a compliance failure for your current supplier base without systematic pre-shipment testing. If you've never had a failure, you might estimate 2-5% probability of a failure in any given shipment without systematic testing. If you've had failures, your historical rate gives you a data point.
Step three: estimate the expected cost of a compliance failure at your scale. Use the categories above: re-testing, air freight premium, mark-down losses, regulatory costs if applicable, relationship costs.
Step four: calculate the expected cost of non-compliance (probability � expected cost). For a modest estimate, 3% probability � 100,000 average failure cost = 3,000 expected cost per shipment from non-compliance risk.
Step five: calculate the cost of a systematic testing programme. For a Pakistan supplier base, a programme including pre-production fabric testing and pre-shipment finished goods testing runs approximately 200-500 per order depending on the scope and the number of suppliers. Multiply by your order volume.
In most scenarios, the systematic testing programme cost is significantly below the expected non-compliance cost. The business case writes itself.
One more thing: the compliance advantage
There's a positive benefit from systematic compliance testing that doesn't appear in cost-of- failure calculations at all: the competitive advantage of supply chain credibility.
Buyers who can demonstrate to their own customers, investors, and regulators that their supply chain has systematic chemical compliance testing with accredited laboratory results are in a different position from buyers who cannot. As CSRD disclosure requirements make supply chain compliance practices increasingly public, the difference between "we have a systematic testing programme with accredited laboratory results across our Pakistan supply chain" and "we test when we think something might be wrong" becomes a brand asset.
The testing programme isn't just insurance. It's evidence of supply chain competence. And supply chain competence is increasingly a commercial differentiator.
For systematic testing programme design and implementation for Pakistan supply chains, contact Tti Labs at customerservices@ttilabs.net or 111-786-001.
cost of compliance,RSL testing,recall risk,testing ROI
Events
Aug 13, 2026
Marking 79 years of Pakistan with our teams across all laboratory sites.
Events
Jul 11, 2025
Driving sustainability, traceability, and carbon strategies for Pakistan’s industries
Events
Dec 13, 2025
Driving climate-aligned innovation and compliance across Pakistan’s export sector


